Stay updated with breaking news from Williamt Roberts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) dropped 10.2% during mid-day trading on Thursday . The company traded as low as $16.43 and last traded at $16.64. Approximately 490,412 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 645,541 shares. The stock had previously closed at $18.52. Analyst […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $20.21, but opened at $18.84. Rhythm Pharmaceuticals shares last traded at $18.44, with a volume of 425,597 shares trading hands. The company reported ($0.92) earnings per […]
Should You Buy or Sell Rhythm Pharmaceuticals Stock? Get The Latest RYTM Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) CAO William T. Roberts sold 912 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $17.50, for a total value of $15,960.00. Following the completion of the sale, the chief accounting officer now directly owns […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) CAO William T. Roberts sold 1,023 shares of Rhythm Pharmaceuticals stock in a transaction dated Tuesday, March 29th. The stock was sold at an average price of $11.13, for a total value of $11,385.99. The transaction was disclosed in a filing with the Securities & Exchange Commission, which […]